Improved pharmaceutical composition containing a ppar alpha...

Details Improved pharmaceutical composition containing a ppar alpha... Improved pharmaceutical composition containing a ppar alpha...

A - Human Necessities

61

K

A61K 31/216 (2006.01) A61K 9/20 (2006.01) A61K 9/48 (2006.01) A61K 31/00 (2006.01) A61K 31/215 (2006.01) A61P 3/06 (2006.01)

Patent

CA 2456713

Oral semi-solid or liquid composition for treating hyperlipidemia or hypercholesterolemia in humans, which comprises at least an effective amount of peroxisome proliferator activated receptor alpha agent (PPARa), one polyglycolized glyceride and one hydrophilic disintegrating agent.

Cette invention porte sur une composition orale semi-solide ou liquide servant au traitement de l'hyperlipidémie ou de l'hypercholestérolémie chez les êtres humains, laquelle composition contient au moins une quantité efficace d'un agent récepteur activé de la prolifération des peroxysomes alpha (PPAR.alpha.), un glycéride polyglycolisé et un agent désagrégeant hydrophile.

Affiliated with

Also associated with

Rating

Improved pharmaceutical composition containing a ppar alpha... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved pharmaceutical composition containing a ppar alpha..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved pharmaceutical composition containing a ppar alpha... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1418280